Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection .
暂无分享,去创建一个
[1] R. Titus,et al. Local Suppression of T Cell Responses by Arginase-Induced L-Arginine Depletion in Nonhealing Leishmaniasis , 2009, PLoS neglected tropical diseases.
[2] C. Wrenger,et al. The activity of Plasmodium falciparum arginase is mediated by a novel inter‐monomer salt‐bridge between Glu295–Arg404 , 2009, The FEBS journal.
[3] Joanne M. Morrisey,et al. Host-parasite interactions revealed by Plasmodium falciparum metabolomics. , 2009, Cell host & microbe.
[4] J. Weinberg,et al. Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria , 2008, Current opinion in infectious diseases.
[5] A. Shoukas,et al. Endothelial Arginase II: A Novel Target for the Treatment of Atherosclerosis , 2008, Circulation research.
[6] S. Kappe,et al. Malaria: progress, perils, and prospects for eradication. , 2008, The Journal of clinical investigation.
[7] D. Conway,et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] R. Price,et al. Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malaria , 2007, The Journal of experimental medicine.
[9] K. Henrick,et al. Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.
[10] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[11] H. Algood,et al. l-Arginine Availability Regulates Inducible Nitric Oxide Synthase-Dependent Host Defense against Helicobacter pylori , 2007, Infection and Immunity.
[12] P. Rodriguez,et al. Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma , 2007, Clinical Cancer Research.
[13] E. Uribe,et al. Mutational analysis of substrate recognition by human arginase type I − agmatinase activity of the N130D variant , 2006, The FEBS journal.
[14] J. Frangos,et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria , 2006, Nature Medicine.
[15] Mark A DePristo,et al. On the abundance, amino acid composition, and evolutionary dynamics of low-complexity regions in proteins. , 2006, Gene.
[16] S. Signoretti,et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. , 2005, Cancer research.
[17] S. Hay,et al. The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.
[18] D. Christianson. Arginase: structure, mechanism, and physiological role in male and female sexual arousal. , 2005, Accounts of chemical research.
[19] J. Boucher,et al. Inhibitor coordination interactions in the binuclear manganese cluster of arginase. , 2004, Biochemistry.
[20] Fourie Joubert,et al. Parasite-specific inserts in the bifunctional S-adenosylmethionine decarboxylase/ornithine decarboxylase of Plasmodium falciparum modulate catalytic activities and domain interactions. , 2004, The Biochemical journal.
[21] L. Aravind,et al. Plasmodium Biology Genomic Gleanings , 2003, Cell.
[22] D. Christianson,et al. Human Arginase II: Crystal Structure and Physiological Role in Male and Female Sexual Arousal†,‡ , 2003 .
[23] Jonathan E. Allen,et al. Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.
[24] A. Gobert,et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Alonso,et al. Glu‐256 is a main structural determinant for oligomerisation of human arginase I , 2001, FEBS letters.
[26] S. Morris,et al. Expression, purification, and characterization of human type II arginase. , 2001, Archives of biochemistry and biophysics.
[27] E. Pizzi,et al. Low-complexity regions in Plasmodium falciparum proteins. , 2001, Genome research.
[28] S. Cederbaum,et al. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. , 2000, Cancer research.
[29] E N Baker,et al. Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily. , 1999, Structure.
[30] S. Cederbaum,et al. Molecular basis of hyperargininemia: structure-function consequences of mutations in human liver arginase. , 1998, Molecular genetics and metabolism.
[31] D. Christianson,et al. Structure of a unique binuclear manganese cluster in arginase , 1996, Nature.
[32] M. Modolell,et al. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines , 1995, European journal of immunology.
[33] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[34] R. Archibald. COLORIMETRIC DETERMINATION OF UREA , 1945 .
[35] R. D. Walter,et al. Structural metal dependency of the arginase from the human malaria parasite Plasmodium falciparum , 2005, Biological chemistry.
[36] P. Stacpoole,et al. Metabolic complications of severe malaria. , 2005, Current topics in microbiology and immunology.
[37] Randy J Read,et al. Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .